Patents Assigned to PHOENIX MOLECULAR DESIGN
  • Patent number: 9771366
    Abstract: Described herein are carboxamide derivatives of Formula (II) that are useful as inhibitors of p90 ribosomal S6 kinase (RSK), pharmaceutical compositions comprising the derivatives, and methods of using the derivatives in treating diseases or conditions associated with RSK activity: wherein R2, R4a, R4b, R11, R12, and n are defined in the specification.
    Type: Grant
    Filed: February 17, 2017
    Date of Patent: September 26, 2017
    Assignee: PHOENIX MOLECULAR DESIGN
    Inventors: Sandra E. Dunn, Aarthi Jayanthan, Jaipal Reddy Nagireddy, Subhash Annedi, John H. Van Drie, Timothy S. Daynard, My-my Huynh